Laurus Labs (LAURUSLABS)
FAST GROWERFairStock Score: 54/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,128.8 |
| Market Cap | ₹58,077.77 Cr |
| P/E Ratio | 68.87 |
| ROCE | 9.15% |
| ROE | 18.86% |
| Dividend Yield | 0.11% |
| Profit Growth | 321.11% |
| Debt/Equity | 0.46 |
| Sales Growth | 27.46% |
| Free Cash Flow | ₹-7,800 Cr |
| Promoter Holding | 27.49% |
| 52-Week Range | ₹641.05 — ₹1,457 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹82.85 |
Laurus Labs trades with a P/E ratio of 68.87, ROCE of 9.15%, ROE of 18.86%, profit growth of 321.11%, debt-to-equity of 0.46. The FairStock Score of 54/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer